ROY A WHITFIELD Insider Trading
Get free email notifications about insider trading for ROY A WHITFIELD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROY A WHITFIELD. ROY A WHITFIELD is a Director in INCYTE CORP ($INCY) and a Director in NEKTAR THERAPEUTICS ($NKTR) and a Director in ILLUMINA INC ($ILMN).
Address: EXPERIMENTAL STATION ROUTE 141 & HENRY CLAY ROAD, BLDG E336 WILMINGTON 19880 DE
Companies in which ROY A WHITFIELD is an Insider
ILLUMINA, INC.
Trading Symbol: ILMNIndustry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of ROY A WHITFIELD: Director
Holdings: 6,853 shares
Current Value: $1,116,011
Latest Transaction: Aug 15 2016
$ILMN Market Capitalization: $23.92B
$ILMN Previous Close: $162.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INCYTE CORP
Trading Symbol: INCYIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of ROY A WHITFIELD: Director
Holdings: 983,389 shares
Current Value: $116,216,912
Latest Transaction: Mar 11 2005
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NEKTAR THERAPEUTICS
Trading Symbol: NKTRIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROY A WHITFIELD: Director
Holdings: 185,850 shares
Current Value: $2,447,645
Latest Transaction: Jan 04 2021
$NKTR Market Capitalization: $2.01B
$NKTR Previous Close: $13.17
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ROY A WHITFIELD
Sentiment: All, ILMN, INCY, NKTR
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 04 2021 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Gift | G | 0.00 | 51,500 | 0 | 51,500 | 0 to 51.5 K |
Jan 04 2021 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Gift | G | 0.00 | 51,500 | 0 | 185,850 | 237.4 K to 185.9 K (-21.70 %) |
Sep 24 2020 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 18.91 | 18,200 | 344,162 | 18,200 | |
Sep 24 2020 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Grant | A | 0.00 | 9,100 | 0 | 237,350 | 228.3 K to 237.4 K (+3.99 %) |
Sep 08 2020 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 9.24 | 30,000 | 277,200 | 0 | |
Sep 08 2020 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 9.24 | 30,000 | 277,200 | 228,250 | 198.3 K to 228.3 K (+15.13 %) |
Dec 20 2019 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 9.24 | 10,000 | 92,400 | 30,000 |